Everyone Healthy Bringing clearer health knowledge to everyone.

Everyone Healthy Library

Antithrombin III Deficiency

Condition / disease reference page from the Everyone Healthy database.

Connected health information

Explore this condition in a clear order

Condition overview

Attributes

Commonalityis 0.3/100

Linked signs and symptoms

5

Each sign/symptom opens its own page and links back to related conditions.

Linked drugs / medications

0

No linked drugs are listed yet.

Treatments, therapies and supportive options

0

Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.

No linked treatment or supportive options are listed yet.

Linked diagnostic tests and investigations

3

These are pulled from both EH diagnostic-test link tables, including the older large test-link table.

Biological and test markers

3

This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.

Introduction / full article

Antithrombin III Deficiency

ID 406

 

Antithrombin III Deficiency

 

Antithrombin III (abbreviated to AT III, or simply AT) is a small protein molecule which contributes towards regulating the coagulation of the blood. A deficiency of AT III causes the blood to clot incessantly (thrombophilia) within the blood vessels.

The condition can be either acquired or inherited. Acquired AT III deficiency is usually caused by an underlying illness, or a significant disruption to the body, often in the form of major surgery. Conversely, inherited AT III is attributed to a rare genetic disorder, with an incidence rate estimated at approximately 1:5000.

Since excessively clotting of the blood can cause myriad problems throughout the entire body, patients are usually treated with anticoagulants, or in some cases, a solution containing concentrated AT III.